The world is witnessing a health innovation renaissance. The leading edges of biological sciences, digital technologies, and geopolitical policies are converging to amplify our ability to monitor, diagnose, manage, treat, and prevent health conditions in ways that are more timely and effective than ever before.
SDGHI and Singapore are contributing regional leadership to the space of Innovation Science for Global Health. The aim is to accelerate access to appropriate and high-impact innovations among low and middle -income countries (LMICs) in Asia and beyond.
This is achieved through (1) Integrating a global health focus within existing programs for the design, refinement and introduction of new and existing innovations from the SingHealth Duke-NUS Academic Medical Centre and partners, to respond to major burdens-of-disease across Asian countries; (2) Identifying and responding to systems-related requirements in priority Asian markets that enable the adoption of innovations-at-scale; and (3) Advancing local capacity for innovation science among partners in priority ASAN markets (and elsewhere) to seed more effective national and regional responses to pressing global health challenges.
Lead: Dr Jonas Erik Sebastian Karlstroem, Innovation Science, Duke-NUS Medical School
Partners: SingHealth Duke-NUS Academic Medical Centre Innovation Institute; the Joint Centre for Technology and Development and Impact Assessment Unit; National University of Singapore; National University of Singapore Biomedical Engineering Program; Singapore University of Technology and Development
Capacity building modules
Innovation Science for Global Health training modules have been developed that leverage existing expertise in the domains of innovation cycles, national health and regulatory systems, and burden-of-disease based priorities. These modules, developed with the support of innovation teams in Singapore, have been tailored to meet diverse learning objectives of students, practitioners and innovators from across Asian countries.
SDGHI and AMC partners are collaborating with national engineering schools to tailor innovations developed in Singapore to the needs of low and middle-income countries. This includes incentivizing innovations that respond to pressing health challenges while facilitating reviews of product landscapes, value-assessments, and deployment opportunities in resource-constrained environments.
SDGHI is working in partnership with national schools of biomedical engineering alongside Schools of Public Health and Academic Medical Centers in Asia on platform for the co-creation of de novo innovations based on jointly identified global health priorities. These efforts respond to high-impact burden of disease conditions across the region while being mindful of system-level capacities and adoption-related bottlenecks in low and middle-income countries.